The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Tumor Necrosis Factor and Chemokine Interactions in the Formation and Maintenance of Granulomas in Tuberculosis
Open accessAbstract
Inflammatory cells migrate to the lungs in response to Mycobacterium tuberculosis infection. These infiltrating cells organize into a structure called a granuloma, which controls and contains infection. The signals that influence the formation of granulomas are largely unknown. Tumor necrosis factor (TNF) has been demonstrated to be required for formation of granulomas, in mouse models of tuberculosis, and for control of latent tuberculosis, in humans. We investigated the mechanisms by which TNF controls cell migration in response to M. tuberculosis infection, focusing on the effects of this cytokine on chemokine expression. Chemokines are small molecules that direct the migration of cells within the body. Our data support the notion that TNF is required for appropriate chemokine expression by M. tuberculosis-infected macrophages, both in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Self-citationGranulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists
Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., & Beenhouwer, D. O. (2004) · Clinical Infectious Diseases · doi:10.1086/383317 · Cited by 977
Mohan, V. P., Scanga, C. A., Yu, K., Scott, H. M., Tanaka, K. E., Tsang, E., Tsai, M. C., Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1847-1855.2001 · Cited by 536
Self-citationTuberculosis: Latency and Reactivation
Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4195-4201.2001 · Cited by 500
Self-citationScanga, C. A., Mohan, V. P., Yu, K., Joseph, H., Tanaka, K., Chan, J., & Flynn, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.347 · Cited by 350
Self-citationAlgood, H. M. S., Chan, J., & Flynn, J. L. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00054-6 · Cited by 240
Self-citationEffects of Aminoguanidine on Latent Murine Tuberculosis
Flynn, J. L., Scanga, C. A., Tanaka, K. E., & Chan, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1796 · Cited by 217
Self-citationAlgood, H. M. S., Lin, P. L., Yankura, D. J., Jones, A. C., Chan, J., & Flynn, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6846 · Cited by 145
Self-citationTumor Necrosis Factor Blockers and Reactivation of Latent Tuberculosis
Keane, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421499 · Cited by 67
Cited by
Revisiting the role of the granuloma in tuberculosis
Ramakrishnan, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3211 · Cited by 883
Foamy macrophages and the progression of the human tuberculosis granuloma
Russell, D. G., Cardona, P.-J., Kim, M.-J., Allain, S., & Altare, F. (2009) · Nature Immunology · doi:10.1038/ni.1781 · Cited by 827
Who puts the tubercle in tuberculosis?
Russell, D. G. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1538 · Cited by 640
Understanding Latent Tuberculosis: A Moving Target
Lin, P. L., & Flynn, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903856 · Cited by 488
Self-citationEssential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung
Okamoto Yoshida, Y., Umemura, M., Yahagi, A., O’Brien, R. L., Ikuta, K., Kishihara, K., Hara, H., Nakae, S., Iwakura, Y., & Matsuzaki, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903332 · Cited by 421
Macrophages and control of granulomatous inflammation in tuberculosis
Flynn, J. L., Chan, J., & Lin, P. L. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.14 · Cited by 417
Self-citationCytokines and Chemokines in Mycobacterium tuberculosis Infection
Domingo-Gonzalez, R., Prince, O., Cooper, A., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 404
Clay, H., Volkman, H. E., & Ramakrishnan, L. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.011 · Cited by 383
Dynamic balance of pro‐ and anti‐inflammatory signals controls disease and limits pathology
Cicchese, J. M., Evans, S., Hult, C., Joslyn, L. R., Wessler, T., Millar, J. A., Marino, S., Cilfone, N. A., Mattila, J. T., Linderman, J. J., et al. (2018) · Immunological Reviews · doi:10.1111/imr.12671 · Cited by 343
Gideon, H. P., Phuah, J., Myers, A. J., Bryson, B. D., Rodgers, M. A., Coleman, M. T., Maiello, P., Rutledge, T., Marino, S., Fortune, S. M., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004603 · Cited by 335
Self-citationGeneral Recommendations on Immunization
(1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430010026011 · Cited by 316
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Siebert, S., Tsoukas, A., Robertson, J., & McInnes, I. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009639 · Cited by 307
Winthrop, K. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0336 · Cited by 280
Gideon, H. P., Hughes, T. K., Tzouanas, C. N., Wadsworth, M. H., Tu, A. A., Gierahn, T. M., Peters, J. M., Hopkins, F. F., Wei, J.-R., Kummerlowe, C., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.004 · Cited by 278
Self-citationHost susceptibility to non-tuberculous mycobacterial infections
Wu, U.-I., & Holland, S. M. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00089-4 · Cited by 265
Lysosomal phospholipase A2: A novel player in host immunity to Mycobacterium tuberculosis
Schneider, B. E., Behrends, J., Hagens, K., Harmel, N., Shayman, J. A., & Schaible, U. E. (2014) · European Journal of Immunology · doi:10.1002/eji.201344383 · Cited by 35
Metadata
- Authors
- Scott Algood, H. M., Lin, P. L., & Flynn, J. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-01
- Volume
- 41
- Issue
- Supplement_3
- Pages
- S189-S193
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108210947
- Cited by
- 278
- References
- 11
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.